Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessment of Kratom Use Disorder and Withdrawal Among an Online Convenience Sample of US Adults
Kirsten E. Smith, Kelly E. Dunn, Jeffrey M. Rogers, et al.
Journal of Addiction Medicine (2022) Vol. 16, Iss. 6, pp. 666-670
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

An update on the clinical pharmacology of kratom: uses, abuse potential, and future considerations
Christopher R. McCurdy, Abhisheak Sharma, Kirsten E. Smith, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 2, pp. 131-142
Closed Access | Times Cited: 18
Kratom safety and toxicology in the public health context: research needs to better inform regulation
Jack E. Henningfield, Oliver Grundmann, Marilyn A. Huestis, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Prevalence of Kratom Use Disorder Among Kratom Consumers
Katherine Hill, Oliver Grundmann, Kirsten E. Smith, et al.
Journal of Addiction Medicine (2024) Vol. 18, Iss. 3, pp. 306-312
Closed Access | Times Cited: 9
Kratom addiction per DSM-5 SUD criteria, and kratom physical dependence: Insights from dosing amount versus frequency
Jeffrey M. Rogers, Stephanie T. Weiss, David H. Epstein, et al.
Drug and Alcohol Dependence (2024) Vol. 260, pp. 111329-111329
Closed Access | Times Cited: 9
Searching for a Signal: Self-Reported Kratom Dose-Effect Relationships Among a Sample of US Adults With Regular Kratom Use Histories
Kirsten E. Smith, Jeffrey M. Rogers, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 36
Examining the paradoxical effects of kratom: a narrative inquiry
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Growing pains with kratom: experiences discussed in subreddits contrast with satisfaction expressed in surveys
Jeffrey M. Rogers, Kayla Colvin, David H. Epstein, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey.
Oliver Grundmann, Charles A. Veltri, Sara Morcos, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 31, Iss. 5, pp. 963-977
Open Access | Times Cited: 14
Unveiling the Complexities of Medications, Substance Abuse, and Plants for Recreational and Narcotic Purposes: An In-Depth Analysis
Iasmina-Alexandra Predescu, Alex-Robert Jîjie, Dalia Pătrașcu, et al.
Pharmacy (2025) Vol. 13, Iss. 1, pp. 7-7
Open Access
Effects of kratom alkaloids on mesolimbic dopamine release
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20
Forensic Implications of Kratom: Kratom Toxicity, Correlation with Mitragynine Concentrations, and Polypharmacy
Donna M Papsun, William Schroeder, Justin O. Brower, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 272-281
Closed Access | Times Cited: 12
Kratom’s Emergence and Persistence Within the US Polydrug Epidemic
Kirsten E. Smith, Jeffrey M. Rogers, Jeffrey D. Feldman
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 262-271
Open Access | Times Cited: 10
Novel methods for the remote investigation of emerging substances: Application to kratom.
Kirsten E. Smith, Jeffrey D. Feldman, Kelly E. Dunn, et al.
Experimental and Clinical Psychopharmacology (2023) Vol. 32, Iss. 2, pp. 215-227
Open Access | Times Cited: 10
Diagnostic Ambiguities and Underuse of Clinical Assessment Tools: A Systematic Review of Case Reports on Kratom Addiction and Physical Dependence
Kirsten E. Smith, Jeffrey D. Feldman, Destiny Schriefer, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 282-292
Closed Access | Times Cited: 9
Correlations of kratom (Mitragyna speciosa Korth.) tea bag preparations and reported pharmacological effects
Oliver Grundmann, Katherine Hill, Everest Al Barzanji, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116779-116779
Closed Access | Times Cited: 9
Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study
C. Austin Zamarripa, Tory R. Spindle, Leigh V. Panlilio, et al.
Traffic Injury Prevention (2024) Vol. 25, Iss. 4, pp. 594-603
Open Access | Times Cited: 3
Need for Clarity and Context in Case Reports on Kratom Use, Assessment, and Intervention
Kirsten E. Smith, Kelly E. Dunn, David H. Epstein, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 1221-1224
Closed Access | Times Cited: 14
Isolated Kratom Use Disorder Treated with Extended-Release Buprenorphine Taper
Benjamin Swart, Charles Reznikoff, Katie Steen
Journal of Addiction Medicine (2024) Vol. 18, Iss. 5, pp. 602-604
Closed Access | Times Cited: 2
Evaluating health information provided to kratom consumers by good manufacturing practice-qualified vendors
Katherine Hill, Stephen Gibson, Oliver Grundmann, et al.
Substance Abuse Treatment Prevention and Policy (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 6
A Preliminary Inventory of Kratom (Mitragyna Speciosa) Products and Vendors on the Darknet and Cryptomarkets
Elisabeth Prevete, Valeria Catalani, Darshan Singh, et al.
Journal of Psychoactive Drugs (2023) Vol. 56, Iss. 4, pp. 485-495
Closed Access | Times Cited: 4
Kratom use and mental health: A systematic literature review and case example
Anil Bachu, Prakamya Singal, Brittany Griffin, et al.
Journal of Addictive Diseases (2023) Vol. 42, Iss. 4, pp. 301-312
Closed Access | Times Cited: 4
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
Kirsten E. Smith, David H. Epstein, Stephanie T. Weiss
Current Psychiatry Reports (2024) Vol. 26, Iss. 9, pp. 487-496
Open Access | Times Cited: 1
For Better or Worse: Self-reported Changes in Kratom and Other Substance Use as a Result of the COVID-19 Pandemic
Jeffrey M. Rogers, Kirsten E. Smith, Destiny Schriefer, et al.
Substance Abuse Research and Treatment (2022) Vol. 16, pp. 117822182211239-117822182211239
Open Access | Times Cited: 5
Kratom use disorder and unfolded protein response: Evaluating their relationship in a case control study
Bin Yang, Ming Tan, Ruiling Zhang, et al.
PLoS ONE (2023) Vol. 18, Iss. 6, pp. e0287466-e0287466
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top